Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based healthcare systems to improve healthcare outcomes. He also discusses how emerging markets are able leverage the fact they have more flexibility than developed markets to implement positive change moving forward.
Could you please expand on some of the key objectives that Novartis has with regards to expanding access to healthcare in emerging markets?
"Our approach to partnership starts with objective understanding of the challenges that governments and healthcare professionals face. We are trying to put ourselves in the shoes of policy makers, apply outside-in thinking, and see the issues from their vintage point."
